Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Achieve

Achieve Life Sciences Inches Closer To FDA Nod For First New Quit-Smoking Drug In 20 Years

Achieve Life Sciences Inc. (NASDAQ:ACHV) is moving closer to a pivotal moment as it seeks FDA approval for cytisinicline, a potential first new smoking cessation therapy in nearly two decades, positioning the company for a high-stakes commercial launch in 2026.

Women’s History Month: Women Wield More Economic Power

Women’s History Month: Women Wield More Economic Power

For Women's History Month, we're highlighting a new study that shows how women are increasing their financial independence, despite the struggles they face.

Tell Customers Your Never-Ending Story With Powerful Branding

Tell Customers Your Never-Ending Story With Powerful Branding

Companies talk to their customers every day through branding. And that's why it's important to know what your brand is saying.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Mother of disgraced operator tries to reopen children’s home closed by Ofsted

Alison McGuinness has applied for regulator’s approval of Bolton facility using new company with different name

The Guardian - UK

Commonwealth Games glory will inspire more than just youngsters - David Smith

AS the curtain came down on Birmingham 2022 Commonwealth Games, those on the Team Scotland Achieve programme were treated to one more sporting…

The National (Scotland)

ACHV: First Quarter 2022 Results

By John Vandermosten, CFA NASDAQ:ACHV READ THE FULL ACHV RESEARCH REPORT

ACHV: 2021 Results: ORCA-3 Underway, ORCA-V1 Soon to Start

By John Vandermosten, CFA NASDAQ:ACHV READ THE FULL ACHV RESEARCH REPORT

inkl

Read news from The Economist, FT, and more,
with one subscription

ACHV: The Final Phase III Begins

By John Vandermosten, CFA NASDAQ:ACHV READ THE FULL ACHV RESEARCH REPORT

Achieve Life Sciences Initiates Pivotal Trial Of Cytisinicline For Smoking Cessation

Achieve Life Sciences Initiates Pivotal Trial Of Cytisinicline For Smoking Cessation

Achieve Life Sciences Inc (NASDAQ: ACHV) has

People

John Vandermosten

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

Silicon Valley Bank

Hewlett Packard Enterprise

Stirling University

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

303,017 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play